Alpha-adrenergic receptor blockers (alpha-blockers) are a class of medications that prevent norepinephrine and epinephrine from binding to alpha receptors.
Alpha-adrenergic receptor blockers are medications that antagonize alpha-adrenergic receptors, preventing the effects of catecholamines (epinephrine and norepinephrine) at these sites.
α1-adrenergic blocking agents safe and effective in the treatment of BPH.
By inhibiting these receptors in the sympathetic nervous system, they relax smooth muscles in blood vessels and the prostate, which helps lower blood pressure and improve urinary flow.
Commonly used alpha – adrenergic blocking medications typically have onset of action within 3 to 7 days and meaningly reduce lower urinary tract symptoms.
Act by relaxing prostate smooth muscle.
Terazosin (Hytrin), doxazosin (Cardura), and tamsulosin (Flomax) alfuzosin (Uroxatral).
Most common side effects include headache, dizziness, asthenia, and drowsiness.
May be associated with retrograde ejaculation.
Terazosin and doxazosin have higher likelihood of orthostasis hypotension than other alpha-1 adrenergic blocking agents.
Alpha-1 adrenergic antagonists additional adverse effects include nasal congestion, edema, palpitations erectile dysfunction and fatigue.
Initially developed as antihypertensive agents.
They work by blocking sympathetic adrenergic-receptor-mediated contraction of the prosthetic smooth muscle cells and bladder neck.
Approved agents include alfuzosin, doxazosin, tamsulosin, terzosin, and silodosin.
Alpha blockers are divided on the basis of their degree of selectivity for the alpha-1-receptor subtype.
Terzosin, doxazosin , and alfuzosin are nonselective, blocking alpha-1 receptor subtypes equally.
The wide distribution of alpha-1 receptors in vascular and CNS tissues explains common side effects of alpha-1 receptor blockers which are hypotension, fatigue, and dizziness.
Tamsulosin and silodosin block alpha1b adrenergic receptors and are selective for alpha1 subtype.
In combination with phosphophodiesterase type 5 inhibitors can cause profound hypotension.
Alpha-adrenergic receptors are divided into α₁ and α₂ subtypes, with α₁ receptors further subdivided into α₁A, α₁B, and α₁D.
All three α₁ subtypes are G-protein-coupled receptors specifically coupled to Gq proteins.
Selective Alpha-1 Blockers: These are the most common type used clinically. They target receptors in vascular smooth muscle and the prostate.
Examples: Tamsulosin (Flomax), Doxazosin (Cardura), Terazosin (Hytrin), Prazosin (Minipress), Alfuzosin (Uroxatral), and Silodosin (Rapaflo).
Non-selective Alpha Blockers: These block both alpha-1 and alpha-2 receptors.
They are typically used for specific conditions like tumors. Examples: Phenoxybenzamine and Phentolamine.
Selective Alpha-2 Blockers: These have limited clinical use in humans but are sometimes used to increase sympathetic activity. Examples: Yohimbine and Idazoxan.
Medical Uses Benign Prostatic Hyperplasia (BPH): Used as a first-line treatment to relax muscles in the bladder neck and prostate, making urination easier.
Hypertension: Used to lower blood pressure by dilating blood vessels.
However, they are now often considered second-line or add-on therapy.
Pheochromocytoma: Non-selective blockers are used preoperatively to manage blood pressure in patients with this rare adrenal gland tumor.
Raynaud’s Disease: Helps improve blood flow to extremities by preventing vessel constriction.
PTSD-Related Nightmares: Prazosin is specifically used to reduce trauma-related nightmares by crossing the blood-brain barrier.
Side Effects and Considerations The most significant side effect is the sudden drop in blood pressure when standing up/orthostatic hypotension, after the initial dose.
For this reason it is often recommended to take the first dose at bedtime.
Other common side effects include: Retrograde ejaculation Erectile dysfunction Fatigue Dizziness and headache. Pounding heartbeat or palpitations. Intraoperative Floppy Iris Syndrome (IFIS): A risk during cataract surgery for patients taking alpha-blockers, particularly Tamsulosin.
Selective α₁-adrenergic blockers (such as prazosin, doxazosin, and terazosin) are the most clinically useful agents in this class.
They lower blood pressure by blocking postsynaptic α₁-adrenoreceptors, which antagonizes catecholamine-induced constriction of arterial and venous vascular beds, thereby reducing peripheral vascular resistance.
Unlike nonselective alpha blockers that block both α₁ and α₂ receptors, selective α₁ blockers preserve the prejunctional α₂-mediated feedback control of norepinephrine release, resulting in minimal reflex tachycardia.
When used long-term, these agents can cause extracellular fluid expansion, which is why combination with diuretics is often beneficial.